Dorff TB - Search Results

1

Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition.

Zang PD, Chawla NS, Barragan-Carrillo R, Chehrazi-Raffle A, Tripathi A, Pal SK, Dorff TB. Zang PD, et al. Among authors: dorff tb. JAMA Oncol. 2024 Apr 1;10(4):531-532. doi: 10.1001/jamaoncol.2023.6817. JAMA Oncol. 2024. PMID: 38329743

2

Novel tyrosine kinase inhibitors for renal cell carcinoma.

Dorff TB, Pal SK, Quinn DI. Dorff TB, et al. Expert Rev Clin Pharmacol. 2014 Jan;7(1):67-73. doi: 10.1586/17512433.2014.862496. Epub 2013 Dec 2. Expert Rev Clin Pharmacol. 2014. PMID: 24308791 Review.

3

Hitting Prostate Cancer Where It Hurts: Maximizing Control of Osseous Metastases.

Dorff TB, Pal SK. Dorff TB, et al. Oncology (Williston Park). 2015 Jun;29(6):424, 426. Oncology (Williston Park). 2015. PMID: 26091675 Free article. No abstract available.

4

Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Yu SS, Dorff TB, Ballas LK, Sadeghi S, Skinner EC, Quinn DI. Yu SS, et al. Among authors: dorff tb. Clin Adv Hematol Oncol. 2017 Jun;15(6):466-477. Clin Adv Hematol Oncol. 2017. PMID: 28749907 Free PMC article. Review.

5

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.

Dorff TB, Longmate JA, Pal SK, Stadler WM, Fishman MN, Vaishampayan UN, Rao A, Pinksi JK, Hu JS, Quinn DI, Lara PN Jr. Dorff TB, et al. Cancer. 2017 Dec 1;123(23):4566-4573. doi: 10.1002/cncr.30942. Epub 2017 Aug 22. Cancer. 2017. PMID: 28832978 Free PMC article. Clinical Trial.

6

Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy.

Bergerot CD, Bergerot PG, Philip EJ, Hsu JA, Dizman N, Vaishampayan U, Dorff T, Pal SK. Bergerot CD, et al. J Immunother Cancer. 2019 Mar 12;7(1):71. doi: 10.1186/s40425-019-0557-5. J Immunother Cancer. 2019. PMID: 30867071 Free PMC article.

7

Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC).

Dorff TB, Quinn DI, Pinski JK, Goldkorn A, Sadeghi S, Tsao-Wei D, Groshen S, Kuhn P, Gross ME. Dorff TB, et al. Clin Genitourin Cancer. 2019 Aug;17(4):241-247.e1. doi: 10.1016/j.clgc.2019.02.010. Epub 2019 Mar 19. Clin Genitourin Cancer. 2019. PMID: 31227432 Free PMC article. Clinical Trial.

8

COVID-19 and androgen-targeted therapy for prostate cancer patients.

Bhowmick NA, Oft J, Dorff T, Pal S, Agarwal N, Figlin RA, Posadas EM, Freedland SJ, Gong J. Bhowmick NA, et al. Endocr Relat Cancer. 2020 Sep;27(9):R281-R292. doi: 10.1530/ERC-20-0165. Endocr Relat Cancer. 2020. PMID: 32508311 Free PMC article. Review.

9

CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade.

Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A. Schweizer MT, et al. JCO Precis Oncol. 2020;4:382-392. doi: 10.1200/po.19.00383. Epub 2020 Apr 21. JCO Precis Oncol. 2020. PMID: 32671317 Free PMC article.

10

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.

Do OA, Ferris LA, Holt SK, Ramos JD, Harshman LC, Plimack ER, Crabb SJ, Pal SK, De Giorgi U, Ladoire S, Baniel J, Necchi A, Vaishampayan UN, Bamias A, Bellmunt J, Srinivas S, Dorff TB, Galsky MD, Yu EY. Do OA, et al. Among authors: dorff tb. Clin Genitourin Cancer. 2021 Apr;19(2):125-134. doi: 10.1016/j.clgc.2020.10.006. Epub 2020 Nov 12. Clin Genitourin Cancer. 2021. PMID: 33309564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page